PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.86%
Revenue growth at 50-75% of AVGO's 9.28%. Martin Whitman would worry about competitiveness or product relevance.
6.66%
Gross profit growth at 50-75% of AVGO's 10.51%. Martin Whitman would question if cost structure or brand is lagging.
7.80%
EBIT growth below 50% of AVGO's 21.40%. Michael Burry would suspect deeper competitive or cost structure issues.
7.80%
Operating income growth under 50% of AVGO's 21.40%. Michael Burry would be concerned about deeper cost or sales issues.
9.06%
Net income growth above 1.5x AVGO's 6.02%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
9.26%
EPS growth above 1.5x AVGO's 4.55%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
9.43%
Diluted EPS growth above 1.5x AVGO's 4.76%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.16%
Share count expansion well above AVGO's 0.24%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.16%
Diluted share count expanding well above AVGO's 0.23%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.16%
Dividend reduction while AVGO stands at 0.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
61.61%
OCF growth of 61.61% while AVGO is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
121.34%
FCF growth above 1.5x AVGO's 0.79%. David Dodd would verify if the firm’s strategic investments yield superior returns.
432.02%
10Y revenue/share CAGR at 50-75% of AVGO's 605.24%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
210.95%
5Y revenue/share CAGR above 1.5x AVGO's 72.57%. David Dodd would look for consistent product or market expansions fueling outperformance.
68.26%
3Y revenue/share CAGR above 1.5x AVGO's 35.72%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
348.22%
10Y OCF/share CAGR under 50% of AVGO's 977.14%. Michael Burry would worry about a persistent underperformance in cash creation.
252.22%
5Y OCF/share CAGR above 1.5x AVGO's 152.38%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
49.01%
3Y OCF/share CAGR 1.25-1.5x AVGO's 34.05%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
700.06%
Similar net income/share CAGR to AVGO's 666.12%. Walter Schloss would see parallel tailwinds or expansions for both firms.
512.90%
5Y net income/share CAGR 1.25-1.5x AVGO's 403.26%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
27.59%
Below 50% of AVGO's 77.94%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
400.49%
10Y equity/share CAGR at 50-75% of AVGO's 638.92%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
229.15%
5Y equity/share CAGR above 1.5x AVGO's 27.46%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
121.37%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
41.32%
Below 50% of AVGO's 606.19%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
6.51%
Below 50% of AVGO's 115.37%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-4.60%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
22.14%
Inventory growth well above AVGO's 11.81%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.11%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.99%
BV/share growth above 1.5x AVGO's 2.30%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.42%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
9.55%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.33%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.